REQUEST – FCF LIFE SCIENCES RESEARCH SERIES

FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.

The findings are regularly published in

Bitte füllen Sie das Pflichtfeld aus.

Salutation

Bitte füllen Sie das Pflichtfeld aus.

Titel

Like Dr., Prof. ...

Bitte füllen Sie das Pflichtfeld aus.

First name

Bitte füllen Sie das Pflichtfeld aus.

Last name

Bitte füllen Sie das Pflichtfeld aus.

E-Mail

Bitte füllen Sie das Pflichtfeld aus.

Position

Bitte füllen Sie das Pflichtfeld aus.

Company

Consent to be contacted

FCF Fox Corporate Finance GmbH (FCF) uses the information in this form to stay in touch with you and to inform you about events and latest market analyses.

Please fill mandatory field

Yes, I agree to be contacted by FCF.*

Bitte füllen Sie das Pflichtfeld aus.

Yes, I agree that FCF can contact me via E-Mail for the purposes of data maintenance.

I agree that for the stated purposes my data will be electronically processed by FCF. I can revoke this consent at any moment in time - without reasoning - and cancel the receipt of the FCF News with immediate effect. FCF will treat my data confidentially and will not disclose it to third parties.

Please fill mandatory field

Yes, I agree with the data protection provisions of FCF.

Learn more about our privacy policy.
* Mandatory fields

** All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request. To verify your request, we therefore need qualified details for the required fields.

FCF Life Sciences Venture Capital Monitor – 06/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 06/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,

July 10, 2020

FCF Life Sciences – Public Equity Monitor 05/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Public Equity Monitor – May 2020”. The Public Equity Monitor, part of FCF Life Sciences Research Series, is the most detailed

July 6, 2020

New Partnership: FCF Life Sciences & YAFO Capital

FCF Fox Corporate Finance and YAFO Capital (Shanghai) announce Joint Venture Munich/Shanghai, June 17th, 2020 – The Life Sciences team at FCF Fox Corporate Finance is expanding its global network of strategic and capital investors

June 17, 2020

FCF Life Sciences Venture Capital Monitor – 05/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 05/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,

June 10, 2020

New Alliance: FCF Life Sciences & Bioscience Valuation

FCF Fox Corporate Finance forms strategic alliance with BioScience Valuation BSV Munich/Grainau, May 20th, 2020 – The Life Sciences team at Fox Corporate Finance GmbH (“FCF”) is collaborating with BioScience Valuation BSV GmbH (“BSV”) as

May 18, 2020

FCF Life Sciences Venture Capital Monitor – 04/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 04/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,

May 8, 2020